Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1397143 | 0.97 | — | — | |
| SCHEMBL1397140 | 0.92 | — | — | |
| SCHEMBL2194733 | 0.90 | — | — | |
| SCHEMBL1397125 | 0.85 | MAPT (0.32) | MAPT | |
| SCHEMBL20304733 | 0.77 | — | — | |
| SCHEMBL1145503 | 0.77 | — | — | |
| SCHEMBL545123 | 0.75 | — | — | |
| SCHEMBL544846 | 0.75 | — | — | |
| SCHEMBL2534602 | 0.74 | — | — | |
| SCHEMBL6521683 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024117165-A1 | ADHESIVE COMPOSITION, ADHESIVE SHEET, ADHESIVE SHEET EQUIPPED WITH MOLD RELEASE FILM, LAMINATE FOR IMAGE DISPLAY DEVICES, IMAGE DISPLAY DEVICE, AND ADHESIVE SHEET FOR ORGANIC EL DISPLAY DEVICES | 三菱ケミカル株式会社 | 2024-06-06 | — | — | WO | disclosed |
| WO-2023190410-A1 | COMPOUND, POLYMERIZABLE COMPOSITION, CURED PRODUCT, COLOR FILTER, PARTITION WALL AND IMAGE DISPLAY DEVICE | 三菱ケミカル株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-2539316-B1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2019-10-23 | — | — | EP | disclosed |
| US-20190171099-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2019-06-06 | — | — | US | disclosed |
| US-10241399-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | BASF SE (DE) | 2019-03-26 | — | — | US | disclosed |
| EP-2668156-B1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2018-10-31 | — | — | EP | disclosed |
| US-9310677-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | BASF (DE) | 2016-04-12 | — | — | US | disclosed |
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2016-03-03 | — | — | US | disclosed |
| US-20140005301-A1 | SULFONIUM SULFATES, THEIR PREPARATION AND USE | BASF SE (DE) | 2014-01-02 | — | — | US | disclosed |
| US-20130308219-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2013-11-21 | — | — | US | disclosed |
| US-20080286693-A1 | Sulfonate derivatives and the use thereof as latent acids | MATSUMOTO AKIRA | 2008-11-20 | — | — | US | disclosed |
| US-7326511-B2 | Sulfonate derivatives and the use thereof as latent acids | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-02-05 | — | — | US | disclosed |
| WO-2007147782-A2 | OXIME SULFONATES AND THE USE THEROF AS LATENT ACIDS | CIBA HOLDING INC. (CH) | 2007-12-27 | — | — | WO | disclosed |
| US-7244544-B2 | Oxime derivatives and the use thereof as latent acids | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-07-17 | — | — | US | disclosed |
| US-20060068325-A1 | Oxime derivatives and the use thereof as latent acids | YAMATO HITOSHI | 2006-03-30 | — | — | US | disclosed |
| US-6986981-B2 | Oxime derivatives and the use thereof as latent acids | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-01-17 | — | — | US | disclosed |
| US-20050153244-A1 | Sulfonate derivatives and the use thereof as latent acids | CIBA SPECIALTY CHEMICALS CORP. | 2005-07-14 | — | — | US | disclosed |
| US-20040002007-A1 | Oxime derivatives and the use thereof as latent acids | CIBA SPECIALTY CHEMICALS CORP. | 2004-01-01 | — | — | US | disclosed |
| EP-1320785-A2 | OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS | Ciba SC Holding AG (CH) | 2003-06-25 | — | — | EP | disclosed |
| WO-2002025376-A2 | OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10241399-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | SULT1E1, COX6B1, SULT1A1 | MAPT 4085/4885 |
| US-20190171099-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | SULT1E1, COX6B1, SULT1A1 | MAPT 4085/4885 |
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | SULT1E1, COX6B1, SULT1A1 | MAPT 4085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.